Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine plus bupivacaine versus bupivacaine alone for erector spinae plane block in minimally invasive cardiac valve surgery
ChiCTR2400094353Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Dec 2024
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Cardiac valve disease (VHD) comparing Bupivacaine hydrochloride group with Liposomal bupivacaine group (2 arms). Primary endpoint: QoR-15 score. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
liposomal bupivacainebupivacaine
03
Conditions
Cardiac valve disease (VHD)
Beyond the preview
Go deeper on ChiCTR2400094353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094353.